diaPatch™
A non-invasive cervical cancer diagnostic patch
Our flagship product, diaPatch™ is a wearable diagnostic patch combining microneedles-mediated interstitial fluid sampling with a molecular assay to support adjunctive cervical risk stratification and triage.
Human-centered designed for the clinical decision gap following abnormal Pap Smear screening.
Non-invasive
Applying a diaPatch™ is as easy as putting on a smart bandage - known as a wearable. A Pap smear is not and it's invasive because it requires a tissue swab from the cervix.
Actionable Workflow
Designed to improve access and operational efficiency for cancer centers, hospitals, clinics, and physician offices, reducing delays, repeat visits, and care pathway friction.
Target same-visit results
diaPatch™ allows for results to be available during the clinical visit while Pap smear results take up to 2 weeks or longer. A scenario that causes much anxiety for patients.
Evidence-Driven Development
Pap testing is highly specific, but sensitivity can be limited (often cited ~55% for high-grade disease), which can delay detection and lead to additional follow-up, often requiring colposcopy, an invasive and resource-intensive step
.png){kind=small}
.png){kind=small}
The Patient Experience
1. A healthcare professional places the patch on the patient's external lower pelvic region
2. Patient waits 30 min for fluid to be analyzed once sampled
3. Patch is removed
4. Results are given during the same clinical visit
5. The companion app, the ELLEApp™ supports result delivery and follow-up reminders.
6. Placement: low external abdominal, just above pelvis
Unsettling Pap Smear Facts
26M
Pap smears Performed Annually in the US
45%
True Positives Are Missed
64%
Women Experience Anxiety Before the Procedure
2wks
To Receive Test Results
Our Milestones
PCT Patent
Currently Fundraising
NSF I-Corps Program
Membership and Accelerators
